Jasperate offering is now closed and is no longer accepting investments.

The inventors of the J-needle™

INVEST IN JASPERATE TODAY!

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Jasperate

REASONS TO INVEST

ABOUT

HEADQUARTERS

VALUATION

TEAM

Dr. Stephen Soloway
Dr. Stephen Soloway
Chief Medical Advisor, Inventor, Director

Originally from New York City, Steve completed undergraduate studies at Stony Brook University. In pursuit of his lifelong dream to be a physician, he attended the American University of the Caribbean School of Medicine in the British West Indies, London, Boston MA, Omaha NE, with post graduate training at Mercy Catholic Medical Center, Misericordia Division, Medical College of Pennsylvania, Philadelphia Veterans Administration Medical Center, and St. Christopher's Hospital for Children. Prior to co-founding Jasperate in March 2017, Steve was the founder of his medical practice, Arthritis & Rheumatology Associates, where he continues to help patients as he has been doing since 1993. Steve has dedicated his life to helping patients and colleagues for decades. He has patients visit him from six countries and many U.S. cities. Steve's devotion to patient’s needs have earned him Top Doctor Awards every year since 2003 and he is regarded as one of the leaders in the Philadelphia, New Jersey, and Delaware area for Rheumatologic care.

Mr. David Weksel
Mr. David Weksel
CEO, President, Director

David has held executive and management positions in strategy and business development with large companies and startups. This includes firms such as Accenture, AT Kearney/Electronic Data Systems, and Lucent New Ventures Group (now Nokia). Early in his career he was an associate in the investment banking group of Paine Webber (acquired by UBS). In the three years prior to co-founding Jasperate in March 2017, David was the Business Development Executive for Davis Legend, a manufacturer and distributor of connectivity solutions. From May 2011 to February 2014, he was the Sr. Director of Business Development for Leviton Manufacturing Company, a manufacturer of electrical components and solutions. David was also the founder of SelectWave, Inc., a startup in the cloud-based mobility space. After launching and operating the company for several years, he subsequently conducted an auction and successfully closed an asset sale of the company. David received certification as a Mergers & Acquisitions Advisor, an MBA in finance from Duke University, and a BS in Mechanical Engineering from Stony Brook University. For the past two years he has been an adjunct professor at the College of DuPage where he teaches entrepreneurship. He is also an inventor of seven U.S. patents and multiple international patents.

Mr. Charles S. Brunner
Mr. Charles S. Brunner
COO, Chief Engineer, Director

As an Engineer and New Product Development Professional, Chuck has spent over thirty years driving to successfully identify white space opportunities, solve development problems, and develop detailed solutions. His extensive experience across diverse products and functions has provided him with a depth of knowledge to address virtually any situation throughout the NPD process. Much of Chuck’s work has involved the coordination of globally diverse groups of internal and external resources to obtain desired results. These experiences provide him with a unique perspective that allows Chuck to bring the right understanding and mindset to each situation and challenge, be it translating technical information into benefits and value for Sales & Marketing, or driving engineering and design to satisfy consumer and market needs. Prior to co-founding Jasperate in March 2017, Chuck was Director of R&D at SharkNinja (formerly Euro-Pro), a manufacturer of small home appliances. Chuck held this position from April 2014 through March 2017. Chuck graduated from Pennsylvania State University with a BS in Mechanical Engineering, has written and spoken multiple times with regard to innovation and opportunity identification, and currently holds fifteen U.S. patents and multiple international patents.

TERMS

Jasperate
Overview
PRICE PER SHARE
DEADLINE
Dec 29, 2017
VALUATION
AMOUNT RAISED
$99,400.00
Breakdown
MIN INVESTMENT
MAX INVESTMENT
MIN NUMBER OF SHARES OFFERED
OFFERING TYPE
Equity
ASSET TYPE
SHARES OFFERED
MAX NUMBER OF SHARES OFFERED

Maximum Number of Shares Offered subject to adjustment for bonus shares

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000:

PRESS

Article Image
Vineland rheumatologist Dr. Soloway save Bridgeton redident with rare disease

Dr. Soloway diagnosed and treated 22 year old woman with a rare disease.

Article Image
N.J. Patients, Doctor Discuss The 'Violent, Unpredictable' Disease

Dr. Soloway discussed disease with patients.

Article Image
Dr. Stephen Soloway Named to "Top Doctors" List by U.S. News & World Report

Dr. Soloway was named one of the nation's top doctors by U.S. News & World Report in collaboration with Castle Connolly.










ALL UPDATES

10.13.17

Thank you to investors

We’re humbled by the support we’ve received from our investors and the StartEngine community. Within two short weeks since the launch of our campaign, we already achieved and surpassed the minimum target. We’re excited to have received investments from several physicians of multiple specialties and other healthcare professionals that see the value of the J-needleTM  and want to use it to improve patient care.

Although we’ve quickly surpassed the minimum target, we’re still a long way off from our maximum target of $100,000. Please share the link for our campaign (https://www.startengine.com/jasperate-inc) on your social media to help get the word out to other potential investors.

Thank you for your support.


The Jasperate Team












JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.